Pet Cancer Therapeutics Market Size, Share, Trends, and Forecast 2025

1. PET CANCER THERAPEUTICS MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Pet Cancer Therapeutics - Overview The global pet cancer therapeutics market, by therapy (Chemotherapy, Targeted Therapy, Combination Therapy, and Immunotherapy), by pet type (Cat, Dog, and Horse), by mode of administration (Oral, Intravenous, and Topical), by application (Lymphoma, Mast Cell Cancer, Melanoma, Mammary and Squamous Cell Cancer, and Others) and by region (North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa), was evaluated at US$ 183.3 million in 2017 and now expected to exhibit a CAGR of 7.7% over the forecast period (2017-2025). Rising global awareness about the importance of early diagnosis of pet cancers, adoption of novel therapies with acclaimed safety profiles, growing veterinary healthcare expenditure, multiple drugs currently in the pipeline, and increasing R&D initiatives are significant aspects that offer a major impetus to the global pet cancer therapeutics market growth. For instance, Karyopharm and Anivive Lifesciences entered into an exclusive license agreement in 2017, for the research, development, and commercialization of Verdinexor (KPT-335) – a drug intended for the treatment of lymphoma. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/pet-cancer-therapeutics-market-1284 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION The U.S. FDA Center for Veterinary Medicine (CVM) has found effectiveness and safety technical sections for Verdinexor to support the conditional approval under a New Animal Drug Application (NADA) for the treatment of canine lymphoma. The drug candidate was further granted the Minor Use & Minor Species (MUMS) designation. The key companies operating in the global pet cancer therapeutics market include Aratana Therapeutics, Inc., AB Science, Boehinger Ingelheim International GmbH, Zoetis, Zenoaq, Morphogenesis, Inc., VetDC, Inc., Karyopharm Therapeutics, Inc., Regeneus Ltd., Rhizen Pharmaceuticals SA, and Oasmia Pharmaceuticals AB. These market contenders are actively engaged in the development, licensing, and commercialization of effective pet therapeutics. For instance, in 2017, Doxosphos Vet, a patented formulation of doxorubicin and the XR17 technology by Oasmia Pharmaceuticals AB, was developed for the treatment of lymphoma in dogs. The drug candidate was subsequently granted the MUMS designation by the U.S. FDA. Furthermore, in 2015, Rhizen Pharmaceuticals S.A. initiated the Phase 2 study of RV1001, a novel oral selective inhibitor of PI3K delta, which is indicated for the treatment of lymphoma in dogs. Moreover, increasing investments by pet owners in disease treatments propel the growth of the global market. As per an annual survey carried out by the American Pet Products Association in 2015, most people in the U.S. spend an estimated US $15.4 billion on veterinary care each year. Request a Sample copy of this reports :https://www.coherentmarketinsights.com/insight/request-sample/1284 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Key Market Takeaways: • position in the global pet cancer therapeutics market, primarily owing to the easy availability of chemotherapy drugs. Among therapy types, the chemotherapy segment holds the foremost • owing to the higher prevalence of cancer among dogs, as compared to the other pets. Among pet types, the dogs segment dominates the global market, • cancer therapeutics market, with the largest number of lymphoma cases among pet animals and a huge number of therapeutics approved for this treatment. In terms of application, the lymphoma segment leads the global pet • Europe, Asia Pacific, and Latin America act as pivotal market growth boosters. Increasing incidence of pet cancers, and high pet adoption rates in Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1284 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved